Detailed Mechanism Funding and Narrative

Years of mechanism: 2008 2009

Details for Mechanism ID: 8711
Country/Region: South Africa
Year: 2008
Main Partner: Tshepang Trust
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $2,477,000

Funding for Testing: HIV Testing and Counseling (HVCT): $386,000

INTEGRATED ACTIVITY FLAG:

Activities are linked to others described in ARV Drugs, ARV Services, and Other Prevention. This is a

follow-on activity to the American Center for International Labor Solidarity.

BACKGROUND:

the FY 2007 PEPFAR funding corporative agreement has enabled the Tshepang Trust to start testing

workplace employees together with their immediate dependents. In the FY 2007 period and going into the

FY 2008, the Trust is focusing on utilizing general practitioners (GPs) to do routine counseling and testing in

their consulting rooms. The Trust although it had a slow start for the FY 2007 period, is gaining momentum

with testing both in GPs rooms and in workplaces through partnerships with other VCT entities, is currently

testing on average 500 individuals per month and the number is rising as the program becomes known with

the assistance of the SA Medical Association in alerting its members on the program.

The emphasis area for this workplace activity is testing for early detection. The target population for this

initiative is men and women of reproductive age working in SMEs, the healthcare and education sector

including their partners and dependents. This includes managers, worker representatives and workers,

educators and other individuals working in the education sector and healthcare workers working in the

public healthcare sector particularly in areas where Tshepang currently has public private partnerships with

some of Gauteng's public ARV sites.

With funding from PEPFAR, these workplace programs will conduct HIV awareness and testing sessions for

both employers and employees on the basic facts of HIV transmission, prevention, and impact of HIV and

AIDS on the industry.

This activity will directly contribute to PEPFAR's goal of preventing 7 million new infections and treating

more than 10 million infected persons. These activities support the USG Five-Year Strategy for South Africa

by expanding and improving quality workplace HIV and AIDS prevention programs and are also in line with

the SA National Strategic Plan.

ACTIVITIES AND EXPECTED RESULTS:

This activity will provide access to VCT services for employees, their partners and their dependents through

referrals to general practitioner (GP) sites and aso workplace wellness facilities. These GPs will provide

counseling and testing and initiation into treatment.

These accomplishments will directly contribute to the realization of PEPFAR's goal to prevent 7 million new

infections and provide care for 10 million people infected with HIV. These accomplishments also support

the prevention, care and treatment goals laid out in the USG Five-Year Strategy for South Africa.

Funding for Treatment: ARV Drugs (HTXD): $1,105,000

INTEGRATED ACTIVITY FLAG:

Activities are linked to others described in Counseling and Testing, and ARV Services. This is a follow-on

activity to the American Center for International Labor Solidarity.

SUMMARY:

This activity is a follow-on to the partnership with the American Center for International Labor Solidarity to

treat South African educators and their spouses and dependents through the Prevention, Care and

Treatment Access Program. This activity as part of the COP between PEPFAR and Tshepang has been

expanded to include individuals in the SMME and Healthcare Sector. With FY 2007 PEPFAR funding, the

USG issued an Annual Program Statement to solicit partners to provide comprehensive testing, care and

treatment services in a workplace setting. The HIV and AIDS TREATMENT activity includes, doctor

consultations, ARVs, related medications e.g. for minor opportunistic infections for a 1,000 patients.

BACKGROUND:

Whilst business has become somewhat more responsive to the needs of its employees to encourage

testing for early detection and treatment of its employees to encourage testing for early detection and

treatment of its employees in larger corporations, the reality is that there are still very low levels of

counseling and testing in the workplace. Employees still do not trust that by enrolling in workplace HIV

programs, they will not be discriminated against. The situation is worse in the small medium enterprises

(SMEs) because unlike big corporations, SMEs are failing to follow the lead of their counterparts in

providing counseling and testing services to their work force. As a result, SMEs need assistance in

providing and developing a workplace response to HIV and AIDS.

The Tshepang Trust (also known as Tshepang) is the South African Medical Association (SAMA)'s

HIV/AIDS program initiated to bridge the gap in medical resources using private general practitioners (GPs)

in the public private partnership model in order to assist the South African government fight against

HIV/AIDS. SAMA has more than 5000 private medical practitioners in the private practice trained in HIV

clinical management. Tshepang has been in existence since June 2003 and is a registered local non

governmental organization (ngo) operating as a trust under Section 21 of the South African Companies Act.

This is a workplace program targeting small medium enterprises (SMMEs) employees, their partners and

dependents using general practitioners and their consulting rooms as sites. For this initiative Tshepang

trust is in the process of forming collaborative relationships with two South African corporate companies to

establish a HIV and AIDS workplace program. In addition to this initiative, Tshepang will work with the

healthcare sector, targeting personnel in hospitals and clinics within the Gauteng area. Lastly, Tshepang

will continue to provide services to educators who received services under the Solidarity Center program

which is ending in December 2007. Tshepang Trust currently has strong evidence of leadership support

from the South African Government through a public private partnership with the Gauteng provincial

department of health to enhance the scale up of HIV counseling and testing (CT) and treatment in

Gauteng's ARV sites. Tshepang currently serves under serviced rural areas in South Africa utilizing general

practitioners who are located mostly in rural areas. Using this model, Tshepang has developed a public-

private partnership between SMEs where employees and their dependents can access private general

practitioners in areas close to where they are employed without fear of discrimination of being absent from

work. In addition all of the general practitioners are within reach of the targeted audiences and are local

and indigenous and therefore able to relate to the target population according to their culture and in local

languages. The geographical coverage area for this project is national. The emphasis area for this

workplace activity is development of networks, linkages, referral systems. The target population for this

initiative is men and women of reproductive age working in SMEs, healthcare and education sectors, their

partners and dependents. This includes factory workers, teachers working in the education sector and

healthcare workers working in the public healthcare sector. The major emphasis area for this activity will be

commodity procurement as is ARVs and medication for minor opportunistic infections and side effects, with

minor emphasis placed on development of network/linkages/referral systems.

ACTIVITIES AND EXPECTED RESULTS:

Through a public-private partnership among workplaces, NGOs and government, participating workplace

programs will employ the services of doctors to provide antiretroviral therapy (ART) to workers who qualify

for treatment. The doctors will be trained in HIV and AIDS clinical management and will have experience in

drug purchasing, ART and PMTCT treatment and surveillance. The doctors will perform a clinical

examination and staging, including taking blood for CD4 testing. A viral load test will be done before the

start of treatment. An adherence counselor will be assigned to each patient and will be responsible for the

continued home-based support and monitoring of the patient's condition. The counselor will also liaise with

the doctor. The treatment services will utilize South African Department of Health standards and guidelines.

All patients will receive their drugs from the doctors' offices. The doctor will ensure that the delivery system

keeps stock of and is able to deliver antiretroviral therapy medications to any physical address. Special

care will be taken to ensure that patient confidentiality is not compromised.

By providing comprehensive ARV services, including patient eligibility testing and drug procurement,

workplace HIV prevention programs will provide HIV-infected workers in small and medium enterprises in

the health and education sector with care and treatment.

These activities will directly contribute to the PEPFAR goal of providing comprehensive HIV and AIDS care

to ten million people and ARV treatment to two million people. These activities will also support the care

and treatment objectives laid out in the USG Five-Year Plan for South Africa.

Funding for Treatment: Adult Treatment (HTXS): $986,000

INTEGRATED ACTIVITY FLAG:

SUMMARY:

This activity is on services rended in order to make the provision and access to ARVS possible for the 1,000

individuals targeted for FY 2007. This activity includes doctor consultations for existing and new patients on

ARVs, patient on a wellness program and laboratory services.

This activity is a follow-on to the partnership with the American Center for International Labor Solidarity.

With FY 2007 PEPFAR funding, the USG issued an Annual Program Statement to solicit partners to provide

comprehensive prevention, care and treatment services in a workplace setting. Tshepang Trust was

selected as one of the partners to continue implementing HIV and AIDS workplace intervention. Treatment

will continue to be provided to workers and their dependents living with HIV in selected small to medium

enterprises (SMEs) in the health and education sector. Care and support for HIV-infected workers will be

provided through wellness programs in workplaces and through referrals to community-based

organizations.

BACKGROUND:

Whilst business has become somewhat more responsive to the needs of its employees to encourage

testing for early detection and treatment of its employees to encourage testing for early detection and

treatment of its employees in larger corporations, the reality is that there are still very low levels of

counseling and testing in the workplace. Employees still do not trust that by enrolling in workplace HIV

programs, they will not be discriminated against. The situation is worse in the small medium enterprises

(SMEs) because unlike big corporations, SMEs are failing to follow the lead of their counterparts in

providing counseling and testing services to their work force. As a result, SMEs need assistance in

providing and developing a workplace response to HIV and AIDS.

The Tshepang Trust (also known as Tshepang) is the South African Medical Association (SAMA)'s

HIV/AIDS program initiated to bridge the gap in medical resources using private general practitioners (GPs)

in the public private partnership model in order to assist the South African government fight against

HIV/AIDS. SAMA has more than 5000 private medical practitioners in the private practice trained in HIV

clinical management. Tshepang has been in existence since June 2003 and is a registered local non

governmental organization (ngo) operating as a trust under Section 21 of the South African Companies Act.

This is a workplace program targeting small medium enterprises (SMEs) employees, their partners and

dependents using general practitioners and their consulting rooms as sites. For this initiative Tshepang

trust is in the process of forming collaborative relationships with two South African corporate companies to

establish a HIV and AIDS workplace program. In addition to this initiative, Tshepang will work with the

healthcare sector, targeting personnel in hospitals and clinics within the Gauteng area. Tshepang Trust

currently has strong evidence of leadership support from the South African Government through a public

private partnership with the Gauteng provincial department of health to enhance the scale up of HIV

counseling and testing (CT) and treatment in Gauteng's ARV sites. Tshepang currently serves under

serviced rural areas in South Africa utilizing general practitioners who are located mostly in rural areas.

Using this model, Tshepang has developed a public-private partnership between SMEs where employees

and their dependents can access private GPs in areas close to where they are employed without fear of

discrimination of being absent from work. In addition all of the general practitioners are within reach of the

targeted audiences and are local and indigenous and therefore able to relate to the target population

according to their culture and in local languages. The geographical coverage area for this project is

KwaZulu-Natal, Mpumalanga, and Eastern Cape Province. The emphasis area for this workplace activity is

development of networks, linkages, referral systems. The target population for this initiative is men and

women of reproductive age working in SMEs, their partners and dependents. This includes factory workers,

teachers working in the education sector and healthcare workers working in the public healthcare sector.

The emphasis areas for this activity will be information, education, communication and development of

network/linkages/referral systems.

ACTIVITIES AND EXPECTED RESULTS:

ACTIVITY 1: GP Network Model

Through a public-private partnership among workplaces, NGOs and government, participating workplace

programs will employ the services of doctors to provide antiretroviral therapy (ART) to workers who qualify

for treatment. The doctors will continue with refresher course training in HIV and AIDS clinical management

and will have experience in drug purchasing, ART and PMTCT treatment and surveillance. The doctors will

perform a clinical examination and staging, including taking blood for CD4 testing of patients. A viral load

test will be done before the start of treatment. The treatment services will utilize South African Department

of Health standards and guidelines. All patients will receive their drugs from the doctors' rooms. The

Tshepang Trust will through its contracted dispensing and delivery service provider ensure that the delivery

system keeps stock of and is able to deliver antiretroviral therapy medications to any physical address.

Special care will be taken to ensure that patient confidentiality is not compromised.

By providing comprehensive ARV services, including patient eligibility testing and drug procurement,

workplace HIV prevention programs will provide HIV-infected workers in small and medium enterprises in

the health and education sector with care and treatment.

ACTIVITY 2: Treatment advocacy campaign

FY 2007 funding will be utilised to provide treatment literacy materials and information on treatment services

available in the respective targeted areas. This may include links for patients to a toll free support line.

Information on how to access testing and treatment services will be disseminated through SMEs, hospitals

and the teachers' and healthcare workers' unions.

ACTIVITY 3: Providing ART services

Workers who are HIV-infected and require ART will be able to access these services through the Tshepang

Activity Narrative: Trust. All workers will receive a unique identifier which will be used for tracking and monitoring the treatment

services and protect the identity of the patient. The Tshepang Trust contracted GPs will provide the range of

ART initiation services, including all relevant laboratory testing, and adherence counseling. The identified

treatment partners will use South African Government treatment guidelines and protocols. About 150

individuals who are not working from the Orange Farm community will be included as part of the 500

existing patients on treatment.

ACTIVITY 4: Monitoring and reporting

The treatment partner will track all relevant patient data for monitoring and reporting purposes.

Providing comprehensive treatment services in a workplace setting will contribute to the PEPFAR 2-7-10

goals. These activities will also support the care and treatment objectives laid out in the USG Five-Year

Plan for South Africa.